SAN DIEGO & DORTMUND, Germany--(BUSINESS WIRE)--PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Inova Diagnostics, ...
SAN DIEGO, June 16, 2014 /CNW/ - INOVA Diagnostics Inc., a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the global launch of ...
Inova Diagnostics, the worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that the United States Food and Drug Administration (FDA) has cleared ...
Aptiva addresses many health economic shortcomings in the autoimmune laboratory. Existing systems provide a limited number of analytes that do not reduce the seronegative gap found in many disease ...
Protagen AG and Inova Diagnostics have signed a semi-exclusive license agreement for BICD2, a novel autoantigen and the first proprietary biomarker discovered by Protagen employing its SeroTag® ...
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug ...
SAN DIEGO, Dec. 21, 2017 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce the global launch ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
innova electronics corporation , a leading supplier of test equipment and diagnostic reporting for the automotive aftermarket, announces the availability of its latest software and firmware release ...
SAN DIEGO, Aug. 26, 2020 /PRNewswire/ -- Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce CE (Conformité ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results